Medscape gives doctors guidance on getting GLP-1 coverage denials reversed for their patients. The full piece has the specifics.
Recap by typeshit. Full story at Medscape.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
The recently retired director of the UNC Diabetes Center is presenting on GLP-1 drugs next Tuesday. The event listing has the details.
Analysts expect a launch around 100,000 won a month, about half of Wegovy's starting price. Its 9.02% average weight loss over 40 weeks trails Mounjaro and Wegovy.
Loading…